Eka Funding
Book a demo
Revolutionary Gene Therapy for Hemophilia A Developed in India
In a landmark achievement, Indian scientists have successfully trialed a novel gene therapy for severe Hemophilia A, potentially eliminating the need for frequent and costly clotting factor injections. The trial, conducted by Dr. Alok Srivastava and his team at the Centre for Stem Cell Research (CSCR), Christian Medical College, Vellore, involved five patients who reported no bleeding episodes over 14 months. The study was recently published in the prestigious New England Journal of Medicine (NEJM).
on
December 13, 2024
Cipla Brings Inhaled Insulin to India
Cipla Limited, has received regulatory approval from the Central Drugs Standard Control Organisation (CDSCO) to distribute and market Afrezza®, a groundbreaking inhaled insulin, in India. This innovation, developed by MannKind Corporation (USA), marks a significant step in diabetes care, providing a needle-free alternative for managing both type 1 and type 2 diabetes mellitus.
on
December 12, 2024
ADA’s 2025 Diabetes Guidelines: What’s New for Better Patient Outcomes?
The American Diabetes Association (ADA) has unveiled its Standards of Care in Diabetes-2025, a comprehensive guide aimed at improving the diagnosis, management, and outcomes of diabetes care. Grounded in the latest research and clinical trials, these guidelines offer actionable strategies to help healthcare professionals deliver optimal care.
on
December 11, 2024
Urine Test Breakthrough for Early Lung Cancer Detection
Cambridge scientists have developed a groundbreaking urine test that could revolutionize early lung cancer detection. The test targets “zombie” cells - damaged cells that linger in tissue and release proteins that aid cancer development. This innovation could enable earlier interventions, improving survival rates for the world’s deadliest cancer.
on
December 10, 2024
“Disease X” Outbreak in Congo Sparks Global Health Alert, Claims 79 Lives.
A mysterious and flu-like illness, dubbed Disease X, has claimed 79 lives and affected 376 individuals in the Democratic Republic of Congo since its emergence in late October. Nearly 200 of the cases involve children under five, while most fatalities are reported among adolescents aged 15 to 18.
on
December 9, 2024
Previous
Next
Featured
Lancet Redefines Obesity: Beyond BMI, A New Medical Perspective
Screen Time at Bedtime Linked to High BP in Young Adults: New Study
ICMR Report Highlights Rising Surgical Site Infections (SSIs) Cases in India: 54% Risk in Orthopaedic Surgeries
50,000 Doctors to Lead India’s Fight Against Cervical Cancer
Breaking Barrier in Malaria Care: WHO Prequalifies First G6PD Test for Safer Treatments
Participate in India’s healthcare revolution
Create ABHA & store all your medical records with Eka care (Govt of India ABDM approved PHR app)
Create ABHA ID
Popular topics
#
newfeature
#
Partnership
#
funding